Irvine Dermatology Specialist Nissan Pilest is a selected Physician Trainer for new Dysport. Dysport is the first rival for Botox. Dr. Pilest met with Medicis CEO Jonah Shacknai at a special Dysport launch meeting in Beverly Hills along with core investigative physicians who were involved in FDA trials for Dysport.
Irvine, CA (PRWEB) August 13, 2009 -- Dr. Nissan Pilest was among a highly select group of physicians invited by Medicis to review specifics on the new product Dysport. A similar neurotoxin to Botox, Dysport was recently approved by the FDA for the treatment of glabellar lines.
The meeting included the major Clinical Trials physicians in California involved in the FDA study. Among these primary study physicians were Drs. Ronald Moy, Ava Shaman, Mark Nestor and John Joseph. Also present was Medicis CEO Jonah Shacknai.
These physicians have had long term experience with the product used for their patients over the course of the FDA trials. Well practiced physicians were invited to the event to have an opportunity to utilize indepth feedback from the actual investigative physicians.
Dr. Pilest has been selected by Medicis as a Physician Trainer for Dysport and he will provide basic and advanced skill injection techniques to newer physicians who wish to bring Dysport to their patients. Dr. Pilest is already a training physician for Medicis' Restylane and Perlane fillers, as well as for Allergan's Juvederm products and Botox, Bioform's Radiesse and laser technologies of Fraxel and Candela.
Dysport was FDA approved after long term studies of over 2,900 patients in more than 80 studies sites across the country.
Dysport and Botox have the same effective action of reducing targeted muscle activity. The primary differences for patients and physicians lie in the dosing unit measurements and the "spread" of the product once injected.
Most physicians report some quicker response time and also some potential increased longevity, though there are not specific study results on longevity as yet. And some patients claim a more "natural" appearance.
Dr. Pilest noted that the discussions by the primary investigators included all the fine points of the most effective treatment specifics.
"Dysport isn't dosed the same as Botox. Patients need to undertand there is no similarity in unit counts between Dysport and Botox. And where some doctors may run into trouble will be in trying to 'standardize' the doses or use a straight conversion ratio between Botox and Dysport. Dysport allows for unique individualized dosage determination by the physician based on many factors such as muscle thickness, depth of dynamic wrinkles and location of the injection," shared Dr. Pilest. "It may well be that the use of both Dysport and Botox will be applicable to some patients depending on where they wish to minimize lines and wrinkles."
Nissan Pilest is a veteran Board Certified Dermatologist with 30 years' experience. He is a training physician for Allergan's Juvederm and Botox, Bioform's Radiesse, Candela Lasers and the Fraxel re:pair CO2 fractional resurfacing laser. He is an assistant professor for University of California Irvine's Dermatology Department. Previous and current affiliation with the renowned Beckman Laser Institute puts him in a "first to know" position for involvement in emerging laser technology.
His private practice, Total Dermatology, is a full service Dermatology and Laser facility located in Irvine, Ca adjacent to Kaiser Permanente on Sand Canyon Avenue. Patients are welcomed and invited to request a personal complimentary consultation. Website http://www.TotalDermatology.com Telephone (949) 727 3800
Read the full story at http://www.prweb.com/releases/dysport/orangecounty/prweb2740674.htm.
Copyright©2009 Vocus, Inc.
All rights reserved